LE VOL 78 - N°5 - SEPTEMBRE OCTOBRE 2023 EST EN LIGNE
Au sommaire
SPECIAL ISSUE
RECENT ADVANCES IN PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY
Pharmacovigilance
·Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
Annie Pierre Jonville-Bera, Sophie Gautier, Joëlle Micallef, Nathalie Massy, Marina Atzenhoffer, Aurélie Grandvuillemin, Milou-Daniel Drici, the French Network of Regional Pharmacovigilance Centres
·Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
Annie Pierre Jonville-Bera, Sophie Gautier, Joëlle Micallef, Nathalie Massy, Marina Atzenhoffer, Milou-Daniel Drici, Aurélie Grandvuillemin, Réseau français des centres régionaux de pharmacovigilance
·COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance
COVID-19 and adenovirus vaccines: French experience of enhanced pharmacovigilance
Nathalie Massy, Marina Atzenhoffer, Charlène Boulay, Pauline-Eva Pecquet, Fanny Ledys, Jean-Luc Cracowski, Kamel Masmoudi, Marion Lepelley, Valérie Gras-Champel
·Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
Marie-Blanche Valnet-Rabier, Martine Tebacher, Sophie Gautier, Joelle Micallef, Francesco Salvo, Antoine Pariente, Haleh Bagheri
·Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
Francesco Salvo, Antoine Pariente, Marie Blanche Valnet-Rabier, Milou-Daniel Drici, Clement Cholle, Clement Mathieu, Allison Singier, Haleh Bagheri, Martine Tebacher, Joelle Micallef, Sophie Gautier, French Network of Regional Pharmacovigilance Centers
·French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
Claire de Canecaude, François Montastruc, Sandrine Bergeron, Paola Sanchez-Pena, Aurélie Grandvuillemin, French Network of Regional Pharmacovigilance Centers
·Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
Aurélie Grandvuillemin, Fanny Rocher, Marie Blanche Valnet-Rabier, Milou-Daniel Drici, Anne Dautriche, the French Pharmacovigilance Network
·Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022
Kevin Bihan, Lorène Lipszyc, Florian Lemaitre, Anne Dautriche, Sophie Fédrizzi, Marina Atzenhoffer, Aurélie Vitores, Annabelle Page, Bénédicte Lebrun-Vignes
Pharmacoepidemiology
·Pharmacoepidemiology and public decision
Mahmoud Zureik, François Cuenot, Bernard Bégaud
·Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
Mahmoud Zureik, François Cuenot, Alain Weill, Rosemary Dray-Spira
·Drugs and the elderly: A complex interaction
Bernard Bégaud, Sybille de Germay, Pernelle Noize
·Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?
Antoine Pariente
·Potentially inappropriate medications and polypharmacy in the older population: A nationwide cross-sectional study in France in 2019
Solène Drusch, Mahmoud Zureik, Marie Herr
·Roll-out and effectiveness of HIV pre-exposure prophylaxis in France: An overview
Sophie Billioti de Gage, Hugo Jourdain, David Desplas, Rosemary Dray-Spira
·Impact of coronavirus disease 2019 on contraception use in France
Noémie Roland, Jérôme Drouin, David Desplas, Lise Duranteau, François Cuenot, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik